
Broadcom, Verizon, CoreWeave, and UnitedHealth, among nine U.S. firms, opposed having their shares tokenized on OKXICE, the OKX–Intercontinental Exchange venue. The refusal is expected. The composition of the list is not, and it reveals who in the corporate world is treating tokenization as a problem to be contained rather than a channel to be managed.
A tech giant, a telecom, a neocloud, and a health insurer have almost nothing in common except one thing: each has a shareholder base, a board mandate, and a disclosure calendar that makes uncontrolled off-hours trading of its own paper an actual operational risk. For those companies, a tokenized share moving 24 hours a day on a venue their disclosure department cannot monitor is not a growth story. It is a new category of event the compliance team has no play for. Their objection is therefore not anti-tokenization in the abstract. It is a statement that the current legal wrapper — no governance rights, no vote, no control over who holds the derivative claim — does not clear the board.
Meanwhile the banks on the other side of the same debate have been quietly repositioning tokenization as a growth opportunity, and the two positions will not survive in the same regulatory frame for long. The GENIUS Act comment deadlines that Hyperliquid is now pressing are where that collision happens: the rule that decides whether a tokenized share is a security, a utility, or a new asset class will decide whether the nine's objection becomes a carve-out or an outlier. The fact that CoreWeave sits on that list is the most telling detail. A company whose own investors are now worrying about neocloud debt stress is the last one anyone expected to be fighting over off-chain trading of its own stock.
Watch the first two SEC rulings that come out of the comment period and whether any of the nine's objections get codified into a mandatory governance right for token holders. The list was expected. The question is whether the regulation it produced will make the next list much shorter.
Image source: i.ibb.co